AlphaCrest Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
AlphaCrest Capital Management's DGX Position: Q4 2022 in Review
AlphaCrest Capital Management sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 8,807 shares — an estimated $1.08M sold.
AlphaCrest Capital Management first reported a position in DGX in Q4 2018 and held it in 15 quarters. The position peaked at $6.47M in Q2 2021. 880 funds tracked by Wall St. Rank hold DGX as of Q4 2022.
- AlphaCrest Capital Management reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
- AlphaCrest Capital Management sold 8,807 Quest Diagnostics shares in Q4 2022, an estimated $1.08M.
- AlphaCrest Capital Management first reported a position in Quest Diagnostics in Q4 2018 and held it in 15 quarters.
- AlphaCrest Capital Management's Quest Diagnostics position peaked at $6.47M in Q2 2021.
- 880 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.
Based on AlphaCrest Capital Management's 13F filing for Q4 2022.